Investing.com - Akebia Ther (NASDAQ: AKBA) reported first quarter EPS of $-0.090, $0.02 worse than the analyst estimate of $-0.070. Revenue for the quarter came in at $32.6M versus the consensus estimate of $46.33M.
Akebia Ther's stock price closed at $1.40. It is down -14.630% in the last 3 months and up 35.920% in the last 12 months.
Akebia Ther saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Akebia Ther's stock price’s past reactions to earnings here.
According to InvestingPro, Akebia Ther's Financial Health score is "good performance".
Check out Akebia Ther's recent earnings performance, and Akebia Ther's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar